Generis Farmacêutica

Generis Farmacêutica is the largest Portuguese pharmaceutical company specializing in the development and manufacturing of solid oral dosage forms, primarily focusing on generic pharmaceuticals. The company has a robust commercial presence in Portugal and exports to Latin America, the Middle East, and North Africa[3][5][6]. It was acquired by Aurobindo Pharma in 2017 for €135 million[5].

• The acquisition included a manufacturing facility with an annual capacity of 1.2 billion tablets/capsules/sachets[5]. Post-acquisition, Aurobindo leveraged Generis’s strong brand recognition and product portfolio to become the leading generics player in Portugal[5].

• No specific clinical trial results are reported as their business centers on commercialized generics rather than novel therapeutics.